155 related articles for article (PubMed ID: 37779952)
1. Synthesis and Anti-Breast Cancer Potency of Mono- and Bis-(pyrazolyl[1,2,4]triazolo[3,4-
Salem ME; Mahrous EM; Ragab EA; Nafie MS; Dawood KM
ACS Omega; 2023 Sep; 8(38):35359-35369. PubMed ID: 37779952
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of new bis(1,2,4-triazolo[3,4-
Thabet FM; Dawood KM; Ragab EA; Nafie MS; Abbas AA
RSC Adv; 2022 Aug; 12(36):23644-23660. PubMed ID: 36090415
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and SARs study of novel spiro-oxindoles as potent antiproliferative agents with CDK-2 inhibitory activities.
Al-Jassas RM; Islam MS; Al-Majid AM; Nafie MS; Haukka M; Rahman AFMM; Alayyaf AMA; Barakat A
Arch Pharm (Weinheim); 2023 Aug; 356(8):e2300185. PubMed ID: 37253118
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and Anti-Proliferative Assessment of Triazolo-Thiadiazepine and Triazolo-Thiadiazine Scaffolds.
Boraei ATA; Ghabbour HA; Gomaa MS; El Ashry ESH; Barakat A
Molecules; 2019 Dec; 24(24):. PubMed ID: 31817609
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antimicrobial testing of 4H-1,2,4-triazole, 1,2,4-triazolo[3,4-b][1,3,4]thiadiazole and 1,2,4-triazolo[3,4-b][1,3,4]thiadiazine derivatives of 1H-benzimidazole.
Habib NS; Soliman R; Ashour FA; el-Taiebi M
Pharmazie; 1997 Nov; 52(11):844-7. PubMed ID: 9399341
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of novel mono- and bis-pyrazolylthiazole derivatives as anti-liver cancer agents through EGFR/HER2 target inhibition.
Salem ME; Mahrous EM; Ragab EA; Nafie MS; Dawood KM
BMC Chem; 2023 Jun; 17(1):51. PubMed ID: 37291635
[TBL] [Abstract][Full Text] [Related]
7. Exploring pyrrolidinyl-spirooxindole natural products as promising platforms for the synthesis of novel spirooxindoles as EGFR/CDK2 inhibitors for halting breast cancer cells.
Nafie MS; Al-Majid AM; Ali M; Alayyaf AA; Haukka M; Ashraf S; Ul-Haq Z; El-Faham A; Barakat A
Front Chem; 2024; 12():1364378. PubMed ID: 38487783
[TBL] [Abstract][Full Text] [Related]
8. New thieno[3,2-d]pyrimidine-based derivatives: Design, synthesis and biological evaluation as antiproliferative agents, EGFR and ARO inhibitors inducing apoptosis in breast cancer cells.
Farghaly AM; AboulWafa OM; Baghdadi HH; Abd El Razik HA; Sedra SMY; Shamaa MM
Bioorg Chem; 2021 Oct; 115():105208. PubMed ID: 34365057
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of New Bioactive Indolyl-1,2,4-Triazole Hybrids As Dual Inhibitors for EGFR/PARP-1 Targeting Breast and Liver Cancer Cells.
Youssef MF; Nafie MS; Salama EE; Boraei ATA; Gad EM
ACS Omega; 2022 Dec; 7(49):45665-45677. PubMed ID: 36530255
[TBL] [Abstract][Full Text] [Related]
10. Characterization of novel heterocyclic compounds based on 4-aryl-4H-chromene scaffold as anticancer agents: Design, synthesis, antiprofilerative activity against resistant cancer cells, dual β-tubulin/c-Src inhibition, cell cycle arrest and apoptosis induction.
Abdelall EKA; A H Elshemy H; Labib MB; E A Mohamed F
Bioorg Chem; 2022 Mar; 120():105591. PubMed ID: 34998122
[TBL] [Abstract][Full Text] [Related]
11. Pyrazolyl-s-triazine with indole motif as a novel of epidermal growth factor receptor/cyclin-dependent kinase 2 dual inhibitors.
Shawish I; Nafie MS; Barakat A; Aldalbahi A; Al-Rasheed HH; Ali M; Alshaer W; Al Zoubi M; Al Ayoubi S; De la Torre BG; Albericio F; El-Faham A
Front Chem; 2022; 10():1078163. PubMed ID: 36505739
[TBL] [Abstract][Full Text] [Related]
12. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, EGFR Inhibition and Anti-cancer Activity of New 3,6-dimethyl-1-phenyl-4-(substituted-methoxy)pyrazolo[3,4-d] pyrimidine Derivatives.
Bakr RB; Mehany ABM; Abdellatif KRA
Anticancer Agents Med Chem; 2017; 17(10):1389-1400. PubMed ID: 28270084
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antimicrobial activities of some new 1-(5-phenylamino-[1,3,4]thiadiazol-2-yl)methyl-5-oxo-[1,2,4]triazole and 1-(4-phenyl-5-thioxo-[1,2,4]triazol-3-yl)methyl-5-oxo- [1,2,4]triazole derivatives.
Demirbas N; Karaoglu SA; Demirbas A; Sancak K
Eur J Med Chem; 2004 Sep; 39(9):793-804. PubMed ID: 15337292
[TBL] [Abstract][Full Text] [Related]
15. The different modes of chiral [1,2,3]triazolo[5,1-b][1,3,4]thiadiazines: crystal packing, conformation investigation and cellular activity.
Obydennov KL; Kalinina TA; Vysokova OA; Slepukhin PA; Pozdina VA; Ulitko MV; Glukhareva TV
Acta Crystallogr C Struct Chem; 2020 Aug; 76(Pt 8):795-809. PubMed ID: 32756043
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, crystal structure and biological evaluation of some novel 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles and 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazines.
Khan I; Zaib S; Ibrar A; Rama NH; Simpson J; Iqbal J
Eur J Med Chem; 2014 May; 78():167-77. PubMed ID: 24681981
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antimicrobial activity of some novel fused heterocyclic 1,2,4-triazolo [3,4-b][1,3,4] thiadiazine derivatives.
Sahu JK; Ganguly S; Kaushik A
J Adv Pharm Technol Res; 2014 Apr; 5(2):90-5. PubMed ID: 24959418
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of novel pyrazole derivatives as anti-inflammatory antimicrobial agents.
Bekhit AA; Ashour HM; Bekhit Ael-D; Bekhit SA
Med Chem; 2009 Mar; 5(2):103-17. PubMed ID: 19275709
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of Some Novel Bis[1, 2, 4]triazolo[3, 4-b][1, 3, 4]thiadiazine Derivatives for Antimicrobial Evaluation.
Reddy CS; Rao DC; Yakub V; Nagaraj A
Acta Chim Slov; 2011 Sep; 58(3):582-9. PubMed ID: 24062120
[TBL] [Abstract][Full Text] [Related]
20. Novel urea and bis-urea primaquine derivatives with hydroxyphenyl or halogenphenyl substituents: Synthesis and biological evaluation.
Perković I; Antunović M; Marijanović I; Pavić K; Ester K; Kralj M; Vlainić J; Kosalec I; Schols D; Hadjipavlou-Litina D; Pontiki E; Zorc B
Eur J Med Chem; 2016 Nov; 124():622-636. PubMed ID: 27614409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
